Dr. Elizabeth Reardon Walsh

M.D. | Pediatrics | Female

Dr. Elizabeth Reardon Walsh, M.D. is a Rochester, New York based Pediatric doctor with medical specialization in General Pediatrics. Dr. Elizabeth Reardon Walsh is also known as Elizabeth Stone Reardon. Current practice location of Dr. Elizabeth Reardon Walsh is 900 Elmgrove Road, Rochester, New York - 14624-6236. She can be contacted on phone at 585-426-4100 and fax number 585-426-3701. Dr. Elizabeth Reardon Walsh is a sole proprietor of her business.
NPI number (Unique professional ID) for Dr. Elizabeth Reardon Walsh is 1154426880 which was assigned by NPPES on 14 Sep, 2006 and it was last updated on 20 Nov, 2019. Dr. Elizabeth Reardon Walsh license number is 225721 for Pediatrics (208000000X) in New York.
Dr. Elizabeth Reardon Walsh is a pediatrician who is concerned with the physical, emotional and social health of children from birth to young adulthood. Care encompasses a broad spectrum of health services ranging from preventive healthcare to the diagnosis and treatment of acute and chronic diseases. A pediatrician deals with biological, social and environmental influences on the developing child, and with the impact of disease and dysfunction on development.
Complete Profile:
Dr. Elizabeth Reardon Walsh basic information including her official name, gender, specialization, credentials etc. are as mentioned below.
Specialization :Pediatrics
Provider Name :Dr. Elizabeth Reardon Walsh
Other Name :Elizabeth Stone Reardon
Credential :M.D.
Gender :Female
Business Address:
Dr. Elizabeth Reardon Walsh address, contact phone number and fax are as below. Patients can directly walkin to the clinic or can call on the below given phone number for appointment.
Primary Address :900 Elmgrove Road
Rochester, NY, 14624-6236
United States
Phone Number :585-426-4100
Fax Number :585-426-3701
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number : 1154426880
NPI Entity Type : Individual
First Enrolment Date : 14 Sep, 2006
Last Updated On : 20 Nov, 2019
Licenses and Specialities:
Physicians/Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Elizabeth Reardon Walsh are as mentioned. Primary taxonomy code for Dr. Elizabeth Reardon Walsh, M.D. is 208000000X (Pediatrics).
Taxonomy Code SpecialityPrimaryLicense No.State
208000000XPediatricsYes225721NY
Legacy Identifiers:
Other legacy medical identifiers of Dr. Elizabeth Reardon Walsh such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned below.
IdentifierIdentifier TypeStateIssuer
02380110MEDICAIDNY
MDH518OtherNYPREFERRED CARE
7429371OtherAETNA US HEALTHCARE
RC60225721OtherPOMCO
7701666OtherNYMVP UPSTATE DHP
P010225721OtherEXCELLUS BLUE CHOICEE
P010225721OtherNYBLUE SHIELD OF ROCHESTER
Endpoints:
Endpoints provide a simple, secure, scalable, and standards-based way for participants to send authenticated, encrypted health information directly to known, trusted recipients over the Internet. It is used by EHR systems (Electronic Health Records).
Endpoint TypeEndpointAffiliationUseContentAddress
DIRECT
(Direct Messaging Address)
lizw@genesispediatrics.medentdirect.com

Medent
No affiliationDIRECT
Direct


900 ELMGROVE ROAD,
ROCHESTER, NY, 14624-6236
United States
Mailing Address:
Mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned business address only.
Mailing Address :900 Elmgrove Rd
Rochester, NY, 14624-6236
United States
Phone Number :585-426-4100
Fax Number :585-426-2026
Business Location:
Patients can refer following map for directions to Dr. Elizabeth Reardon Walsh practice address. Don't forget to take prior appointment before visiting.

** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 January, 2024.